Derebail publishes article that may explain different treatment needs for African American dialysis patients
Vimal K. Derebail, MD, MPH, has authored a study, “Variant hemoglobin phenotypes may account for differential erythropoietin-stimulating agent dosing in African-American hemodialysis patients” published on-line on August 17 in Kidney International. In this study, Dr. Derebail and his colleagues evaluated the influence of abnormal hemoglobin variants including sickle cell trait on the response to anemia … Read more